Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhancing the circulating half-life of antibody-based fusion proteins

Enhancing the circulating half-life of antibody-based fusion proteins

US Patent 7790415 · Granted Sep 7, 2010

Estimated economic value: $60,580,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-L1 antibodies2025
Humanized and de-immunized antibodies2024
Anti-PD-L1 and IL-2 cytokines2024
Light chain immunoglobulin fusion proteins and methods of use thereof2022
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in2022
Targeted TGFβ inhibition2022
Humanized antibodies2021
SIRP-α immunoglobulin fusion proteins2021
Anti-cancer antibodies with reduced complement fixation2020
Humanized antibodies2020
Antibodies and immunocytokines2020
Anti-cancer antibodies with reduced complement fixation2018